Sundrug Co.,Ltd. (SDGCF)
USD 28.18
(-9.01%)
USD 28.18
(-9.01%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 40.99 Billion JPY | 14443.07% |
| 2023 | 281.89 Million JPY | 0.77% |
| 2022 | 279.73 Million JPY | -17.23% |
| 2021 | 337.97 Million JPY | -0.33% |
| 2020 | 339.08 Million JPY | 6.52% |
| 2019 | 318.32 Million JPY | -6.17% |
| 2018 | 339.26 Million JPY | 11.01% |
| 2017 | 305.62 Million JPY | 4.01% |
| 2016 | 293.82 Million JPY | -98.87% |
| 2015 | 25.92 Billion JPY | -7.6% |
| 2014 | 28.05 Billion JPY | 13.5% |
| 2013 | 24.72 Billion JPY | 11.04% |
| 2012 | 22.26 Billion JPY | 15.76% |
| 2011 | 19.23 Billion JPY | 20.05% |
| 2010 | 16.02 Billion JPY | 7.94% |
| 2009 | 14.84 Billion JPY | 6.09% |
| 2008 | 13.98 Billion JPY | 9.72% |
| 2007 | 12.75 Billion JPY | 3.26% |
| 2006 | 12.34 Billion JPY | 11.65% |
| 2005 | 11.05 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 89.34 Million JPY | 24.67% |
| 2024 Q1 | 68.59 Million JPY | 14.5% |
| 2024 Q2 | 71.66 Million JPY | 4.48% |
| 2024 Q4 | 7.78 Billion JPY | 8607.74% |
| 2024 FY | 40.99 Billion JPY | 14443.07% |
| 2023 FY | 281.89 Million JPY | 0.77% |
| 2023 Q3 | 83.72 Million JPY | 28.22% |
| 2023 Q2 | 65.29 Million JPY | -2.11% |
| 2023 Q1 | 66.7 Million JPY | 22.84% |
| 2023 Q4 | 59.9 Million JPY | -28.45% |
| 2022 Q2 | 74.82 Million JPY | -13.49% |
| 2022 Q1 | 86.49 Million JPY | 30.23% |
| 2022 Q3 | 82.62 Million JPY | 10.43% |
| 2022 Q4 | 54.3 Million JPY | -34.28% |
| 2022 FY | 279.73 Million JPY | -17.23% |
| 2021 Q2 | 8.97 Billion JPY | -16.16% |
| 2021 FY | 337.97 Million JPY | -0.33% |
| 2021 Q1 | 10.7 Billion JPY | 21.1% |
| 2021 Q4 | 66.41 Million JPY | -99.36% |
| 2021 Q3 | 10.33 Billion JPY | 15.2% |
| 2020 Q2 | 10.25 Billion JPY | 7.4% |
| 2020 FY | 339.08 Million JPY | 6.52% |
| 2020 Q1 | 9.55 Billion JPY | 15.35% |
| 2020 Q3 | 7.96 Billion JPY | -22.38% |
| 2020 Q4 | 8.83 Billion JPY | 10.99% |
| 2019 FY | 318.32 Million JPY | -6.17% |
| 2019 Q1 | 8.87 Billion JPY | 3.93% |
| 2019 Q2 | 8.31 Billion JPY | -6.28% |
| 2019 Q3 | 9.76 Billion JPY | 17.35% |
| 2019 Q4 | 8.27 Billion JPY | -15.18% |
| 2018 Q4 | 8.53 Billion JPY | -14.95% |
| 2018 Q3 | 10.04 Billion JPY | 16.07% |
| 2018 Q2 | 8.65 Billion JPY | -2.27% |
| 2018 Q1 | 8.85 Billion JPY | 8.68% |
| 2018 FY | 339.26 Million JPY | 11.01% |
| 2017 FY | 305.62 Million JPY | 4.01% |
| 2017 Q3 | 9.5 Billion JPY | 17.46% |
| 2017 Q2 | 8.09 Billion JPY | -2.63% |
| 2017 Q1 | 8.31 Billion JPY | 7.57% |
| 2017 Q4 | 8.14 Billion JPY | -14.33% |
| 2016 FY | 293.82 Million JPY | -98.87% |
| 2016 Q2 | 8.39 Billion JPY | 8.1% |
| 2016 Q1 | 7.76 Billion JPY | 11.46% |
| 2016 Q3 | 9.14 Billion JPY | 9.02% |
| 2016 Q4 | 7.72 Billion JPY | -15.52% |
| 2015 FY | 25.92 Billion JPY | -7.6% |
| 2015 Q1 | 5.28 Billion JPY | -28.11% |
| 2015 Q4 | 6.96 Billion JPY | -13.18% |
| 2015 Q3 | 8.02 Billion JPY | 41.85% |
| 2015 Q2 | 5.65 Billion JPY | 6.94% |
| 2014 Q4 | 7.35 Billion JPY | 3.56% |
| 2014 FY | 28.05 Billion JPY | 13.5% |
| 2014 Q1 | 6.42 Billion JPY | 3.45% |
| 2014 Q2 | 7.18 Billion JPY | 11.8% |
| 2014 Q3 | 7.1 Billion JPY | -1.1% |
| 2013 Q4 | 6.2 Billion JPY | -5.39% |
| 2013 FY | 24.72 Billion JPY | 11.04% |
| 2013 Q1 | 5.49 Billion JPY | -7.53% |
| 2013 Q2 | 6.45 Billion JPY | 17.35% |
| 2013 Q3 | 6.56 Billion JPY | 1.7% |
| 2012 Q3 | 5.63 Billion JPY | 1.72% |
| 2012 Q2 | 5.53 Billion JPY | 7.68% |
| 2012 Q1 | 5.14 Billion JPY | 2.74% |
| 2012 FY | 22.26 Billion JPY | 15.76% |
| 2012 Q4 | 5.94 Billion JPY | 5.54% |
| 2011 Q1 | 4.17 Billion JPY | 3.52% |
| 2011 Q3 | 5.19 Billion JPY | 7.13% |
| 2011 Q2 | 4.85 Billion JPY | 16.35% |
| 2011 FY | 19.23 Billion JPY | 20.05% |
| 2011 Q4 | 5 Billion JPY | -3.69% |
| 2010 Q3 | 3.79 Billion JPY | -15.37% |
| 2010 Q1 | 3.7 Billion JPY | 0.0% |
| 2010 FY | 16.02 Billion JPY | 7.94% |
| 2010 Q4 | 4.02 Billion JPY | 6.05% |
| 2010 Q2 | 4.48 Billion JPY | 21.29% |
| 2009 FY | 14.84 Billion JPY | 6.09% |
| 2008 FY | 13.98 Billion JPY | 9.72% |
| 2007 FY | 12.75 Billion JPY | 3.26% |
| 2006 FY | 12.34 Billion JPY | 11.65% |
| 2005 FY | 11.05 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -261.11 USD | 15700662656.011% |
| Allstar Health Brands, Inc. | -215.75 Thousand USD | 19001722.248% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 624.14 Million USD | -6468.303% |
| Café Serendipity Holdings, Inc. | -1.43 Million USD | 2856776.984% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -47.57 Thousand USD | 86180465.777% |
| HealthWarehouse.com, Inc. | -1.62 Million USD | 2528095.659% |
| LIGAND PHARMACEUTICAL INC | 9.82 Million USD | -417332.033% |
| MedGen, Inc. | -15.54 USD | 263809523909.524% |
| Omni Health, Inc. | 405.52 Thousand USD | -10109389.051% |
| Oxford Investments Holdings Inc. | -342.3 Thousand USD | 11976623.723% |
| Pineapple, Inc. | -1.47 Million USD | 2774531.592% |
| ScripsAmerica, Inc. | -3.8 Million USD | 1076872.435% |